SHANGHAI, May 20, 2024
/PRNewswire/ -- Duoning Biotechnology Group ("Duoning"), a leading
one-stop bioprocess provider in China, today announced a strategic partnership
with Bioelectronica, a company focusing on developing tools for
single-cell/single-bacteria research. This partnership aims to
enhance the global commercialization of the high-throughput
single-cell sorting system Hypercell® and other related
products. With joint efforts, the two companies will provide an
economical and efficient solution for antibody discovery by
utilizing advanced target cells screening technology.
Monoclonal antibodies play a critical role in the life science
industry and are essential therapeutics for treating tumors
and autoimmune diseases. The traditional process for
monoclonal antibody discovery is time-consuming, limiting the
efficient development of these antibodies. Hypercell®, a
high-throughput single-cell sorting system based on bright-field
single B cell sorting, leverages advanced microfluidics and
artificial intelligence visual recognition technology to conduct
screening experiments on tens of thousands of single cells
within 2 hours. With its high throughput, user-friendly
operation and ability to complete cell sorting within a day, this
system is widely appliable in research and commercialization stages
in various fields such as antibodies, ADCs and cell therapy, while
significantly shortening the development cycle of antibodies.
Relying on two core sorting technologies for single-cell and
single-bacteria, Bioelectronica is able to offer end-to-end
solutions for biological research. As a preferred partner, Duoning
has established an extensive global sales network and a mature
business platform spanning the entire bioprocess chain. As a key
aspect of this collaboration, both parties will support researchers
in precise manipulation and efficient screening of single cells,
thereby accelerating the speed of antibody development and
simplifying the process of biopharmaceutical research and
development.
"We are delighted to partner with Bioelectronica, a company
known for its cutting-edge single-cell sorting technologies and
robust product development capabilities. Our joint efforts will
further meet customers' demands for top-tier scientific instruments
and comprehensive bioprocess solutions," said Gu Hongfeng, Vice
President at Duoning. "In this collaboration, we will introduce
premium domestic instruments to the international market to
increase the efficiency of antibody discovery and development
worldwide."
"Bioelectronica offers excellent services to customers with its
high-throughput, rapid single-cell sorting technology and
user-friendly, widely-applicable equipment. On the other hand,
Duoning is able to ensure efficient, reliable biologics production
with its one-stop bioprocess solutions. By establishing a strong
partnership, we will deliver solutions to customers ranging from
cell screening to process optimization. And I am looking forward to
creating more value and benefits for the biopharmaceutical industry
with Duoning." said Sun Jianjun, the
Founder of Bioelectronica.
About Duoning
Shanghai Duoning Biotechnology Co., Ltd. ("Duoning") is a
leading one-stop bioprocess solutions provider in China, committed to offering products and
services required for the discovery, development and
commercialization production of biologics, including reagents,
consumables, instruments, equipment, and validation services.
Leveraging our integrated bioprocess system, we empower our
partners to achieve effective, reliable, lower-cost and
higher-quality biologics production processes. For more
information, please visit: www.duoningbio.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/duoning-collaborates-with-bioelectronica-to-commercialize-a-single-cell-sorting-system-for-antibody-discovery-302149975.html
SOURCE Duoning Biotechnology